INDUSTRY: Health
Dr. Lauren Bowen Reoma is a Staff Clinician and Medical Director of the National Institute of Neurological Disorders and Stroke (NINDS) Clinical Trials Unit in the Office of the Clinical Director where she oversees the centralized support for NINDS sponsored IND and IDE clinical trials and Data and Safety Monitoring procedures, as well as serves as the Medical Monitor for selected NINDS sponsored trials. She is a board-certified neurologist who received her medical degree from the University of Florida in May 2011. She completed her Internal Medicine Internship at the University of Florida College of Medicine in 2012 and completed her neurology residency at the University of Florida College of Medicine in 2015. From 2015-2019, she trained as a Clinical Fellow in the NINDS Neuroimmunology and Neurovirology Program where she completed additional training in Clinical Trials Methodology and the FDA Clinical Investigator Training.
Dr. Reoma has expertise in conducting clinical studies in HIV-infected patients and was elected as a member of the AIDS Clinical Trials Group (ACTG) End-organ Disease, the Inflammation Transformative Science Group and the ACTG Neurology Collaborative Science Group. She is the lead investigator on an FDA approved clinical study. NCT03239899: PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection; IND 13390. She is an Associate Investigator on several other studies. This includes, NCT03367754: A single dose of Pembrolizumab in HIV-infected people: NCT02437/ IO: HERV-K Suppression Using Antiretroviral Therapy in Volunteers with Amyotrophic Lateral Sclerosis (Al,S); NCT02435810: Inflammatory and Infectious Diseases of the Nervous System and NCTO J 86210 7: Cerebrospinal Fluid Collection and Repository Storage. She also has experience as a member of the Safety Monitoring Committee on a Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency and as an Independent Monitor on a Phase l Cytokine microdialysis for real time immune monitoring in glioblastoma patients undergoing checkpoint blockade.
RETURN TO HONOREE LIST